Cite

    Manokumar, T. et al. (2016). A prospective study examining elder-relevant outcomes in older adults with prostate cancer undergoing treatment with chemotherapy or abiraterone. Journal of geriatric oncology. 7 (2), pp. 81-89. [Online].